About
Research & Development
Neurodegenerative Diseases
News & Publications
Contact
Who we are
About
PharmatrophiX
About
Our mission, story, and approach.
Leadership
Team, board, and scientific advisors
Peer Reviewed Funding & Investors
Our science
Research &
Development
Research & Development
Our science and development philosophy.
Pipeline
Programs and indications across our development stages.
Clinical
·
July 28, 2026
·
read
Dr. Frank Longo, Stanford University professor of neurology and PharmatrophiX co-founder, joins ‘Squawk Box’ to discuss the company’s new Alzheimer’s drug LM11A-31
Share
Keep reading
More from the newsroom.
All stories →
Stay informed
New data, new trials, occasional essays. No more than monthly.
Leave this field empty if you're human:
Unsubscribe anytime. We never share your email.
